.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Colorcon
Harvard Business School
Medtronic
Cantor Fitzgerald
Baxter
Covington
US Department of Justice
Chubb
McKesson

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077122

« Back to Dashboard
NDA 077122 describes DESMOPRESSIN ACETATE, which is a drug marketed by Sun Pharm Inds, Apotex Inc, Hospira, Impax Labs Inc, Bausch And Lomb, Glenmark Pharms Ltd, Sagent Pharms, Mylan Pharms Inc, Actavis Labs Fl Inc, Bedford, Sun Pharm Inds Ltd, Heritage Pharma, Teva Pharms Usa, Ferring, Zydus Pharms Usa Inc, and Sun Pharma Global, and is included in nineteen NDAs. It is available from nineteen suppliers. Additional details are available on the DESMOPRESSIN ACETATE profile page.

The generic ingredient in DESMOPRESSIN ACETATE is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

Summary for 077122

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 077122

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL 077122 ANDA Teva Pharmaceuticals USA, Inc. 0093-7316 0093-7316-01 100 TABLET in 1 BOTTLE (0093-7316-01)
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL 077122 ANDA Teva Pharmaceuticals USA, Inc. 0093-7317 0093-7317-01 100 TABLET in 1 BOTTLE (0093-7317-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.1MG
Approval Date:Jan 25, 2006TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.2MG
Approval Date:Jan 25, 2006TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
QuintilesIMS
Cerilliant
Fish and Richardson
McKesson
Julphar
Dow
Healthtrust
Express Scripts
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot